76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Quest Diagnostics Inc
Open
SectorHealthcare
174.72 0.16
Overview
Share price change
24h
Min
172.51
Max
175.23
Income | 13M 235M |
|---|---|
Sales | 31M 2.7B |
P/E Sector Avg | 22.02 51.198 |
EPS | 2.21 |
Dividend yield | 1.83 |
Profit margin | 8.861 |
Employees | 55,000 |
EBITDA | -19M 488M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +8.74% upside |
Dividend yield Sector Avg | 1.83% 2.40% |
|---|---|
Next Earnings | 22 Jul 2025 |
Next Dividend date | 21 Jul 2025 |
Next Ex Dividend date | 7 Jul 2025 |
Market Cap | 577M 19B |
|---|---|
Previous open | 174.56 |
Previous close | 174.72 |
News Sentiment
By Acuity
17%
83%
29 / 380 Healthcare
Technical Score
By Trading Central
Confidence
Bullish Evidence
Quest Diagnostics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Quest Diagnostics Inc Forecast
Price Target
By TipRanks
8.74% upside
12 Months Forecast
Average 188.83 USD 8.74%
High 200 USD
Low 175 USD
Based on 14 Wall Street analysts offering 12 month price targets forQuest Diagnostics Inc - Dist in the last 3 months.
Sentiment
By Acuity
29 / 380 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
